STAT3 and T-cell large granular lymphocyte leukemia: Regarding the dysregulation of molecular pathways, LGL cells have been found to display increased activated signal transducer and STAT3 levels; therefore, treatment with in vitro JAK-selective tyrosine kinase inhibitor, AG-490, induced apoptosis in LGL leukemia and decreased STAT3-DNA binding activity [72].